Browse Items (9 total)
- Tags: Survival Analysis
Transplant radical nephrectomy and transplant radical nephroureterectomy for renal cancer: Postoperative and survival outcomes.
Tags: 2020, Annals of transplantation, Holzman S, Hong G, journalArticle, Kidney Neoplasms, Kim FY, Makhani SS, Master Viraj A, Nabavizadeh R, NEOMED College of Medicine Student, NEOMED Student Publications, Nephrectomy, Noorali AA, October 2020 List, Ogan K, Patil DH, Survival Analysis, Tso PL, Turgeon NA
Feasibility and safety of adopting next-day discharge as first-line option after transfemoral transcatheter aortic valve replacement.
Tags: 2019, Academic Medical Centers, Aged, Aged 80 and over, aortic stenosis, Aortic Valve Stenosis/diagnosis/surgery, Attizzani GF, Bezerra HG, Cleveland Clinic Akron General Hospital, Cohort Studies, Costa MA, Davis A, Department of Internal Medicine, early discharge, Feasibility Studies, Female, Follow-Up Studies, Humans, Ichibori Y, journalArticle, June2020SubmittedList, Kalra A, Length of Stay, Li J, Lipinski J, Male, Markowitz AH, minimalist approach, NEOMED College of Medicine, next-day discharge, Ohio, Panhwar M, Patel SM, Patel TM, Patient Discharge, Patient Readmission/statistics & numerical data, Patient Safety, Propensity Score, Qureshi G, Retrospective Studies, Risk Assessment, Sareyyupoglu B, Saric P, Severity of Illness Index, Survival Analysis, The Journal of invasive cardiology, Time Factors, transcatheter aortic valve replacement, Transcatheter Aortic Valve Replacement/methods/mortality, United States, Zidar DA
Tags: 2015, 80 and over, Aged, Bacterial/*diagnosis/*mortality/therapy, Bahl Jaya, Bautista Manuel, Biological Markers – Therapeutic Use, BioMed research international, CINAHL Database, Cross Infection/*diagnosis/*mortality/therapy, Department of Internal Medicine, Dhawan Naveen, Duggal Anurag, Embase, Female, Gupta Vineet, Homes for the Aged/statistics & numerical data, Human, Humans, Incidence, Khalili Michael, Male, Medline, Meta Analysis, Mortality – Risk Factors, NEOMED College of Medicine, Nursing Care/*statistics & numerical data, Nursing Home Patients, Nursing Homes/*statistics & numerical data, Pandya Naushira, Pneumonia, Pneumonia – Risk Factors, Prognosis, Risk Assessment/methods, Severity of Illness Index, Survival Analysis, systematic review, Treatment Outcome
Predictive model for survival in patients having repeat radiation treatment for painful bone metastases.
Tags: *Models, 2016, Aged, Babington Scott, Bone metastases, Bone Neoplasms/*mortality/*radiotherapy/secondary, Brundage Michael, Chow Edward, Demas William F, Ding Keyue, Dose Fractionation, Female, Hartsell William F, Hoskin Peter, Humans, Leer Jan Willem, Male, Meyer Ralph M, Middle Aged, Nabid Abdenour, Parulekar Wendy R, Predictive model, Predictive Value of Tests, Proportional Hazards Models, Radiation, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Randomized Controlled Trials as Topic/methods, Re-irradiation, Roos Daniel, Statistical, Survival, Survival Analysis, Survival Rate, van der Linden Yvette M, Vonk Ernest, Wilson Carolyn F, Wong Rebecca K S, Wu Jackson S Y, Zhu Liting
Tags: 2016, African Americans/*statistics & numerical data, Blacks – Statistics and Numerical Data, Comparative Studies, Comprehension, Department of Internal Medicine, European Continental Ancestry Group/*statistics & numerical data, Evaluation Research, Female, Human, Humans, Journal of the American Academy of Dermatology, Kailas Ajay, Kittles Rick, Male, Melanoma – Mortality, Melanoma – Pathology, Melanoma – Therapy, Melanoma/mortality/pathology/*therapy, Mostow Eliot N, Multicenter Studies, Needs Assessment, NEOMED College of Medicine, Readability, Rigel Darrell S, Risk Assessment, Skin Neoplasms – Mortality, Skin Neoplasms – Pathology, Skin Neoplasms – Therapy, Skin Neoplasms/mortality/pathology/*therapy, Skin Pigmentation – Physiology, Skin Pigmentation – Radiation Effects, Skin Pigmentation/physiology/radiation effects, Solomon James A, Survival Analysis, Taylor Susan C, Ultraviolet Rays – Adverse Effects, Ultraviolet Rays/*adverse effects, United States, Validation Studies, Whites – Statistics and Numerical Data
Tags: *beta-Lactam Resistance, 2016, 80 and over, Aged, Bacteremia/microbiology/mortality, Bacterial/microbiology/mortality, Bonomo R A, carbapenem-resistant Enterobacteriaceae, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Cober E, Department of Internal Medicine, Doi Y, Epidemiology, Evans S, Female, Fowler V G Jr, Hauck C, Humans, Kalayjian R C, Kaye K S, Klebsiella Infections/*microbiology/*mortality, Klebsiella pneumoniae, Klebsiella pneumoniae/*drug effects/isolation & purification, Longitudinal Studies, Male, Middle Aged, Mortality, NEOMED College of Medicine, Perez F, Pneumonia, Prospective Studies, Richter S S, Salata R A, Scalera N M, Survival Analysis, Urinary Tract Infections/microbiology/mortality, van Duin D, Watkins R R
Tags: 2005, Animals, Antiviral Agents/administration & dosage/pharmacology/*therapeutic use, Antiviral research, Booth Tristan, Docherty John J, Drug Evaluation, Faith Seth A, Female, Fu Ming Ming, Hah Jennifer M, Herpes Genitalis/*drug therapy/pathology/virology, Herpesvirus 1, Herpesvirus 2, Human/*drug effects/physiology, Human/drug effects/isolation & purification/physiology, Mice, Placebos, Preclinical, Resveratrol, Stilbenes/administration & dosage/pharmacology/*therapeutic use, Survival Analysis, Sweet Thomas J, Vaginal Diseases/*drug therapy/virology, Viral Plaque Assay, Virus Replication/drug effects
Tags: 2005, Adult, Aged, Akram Tahira, American journal of obstetrics and gynecology, Antineoplastic Agents, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Carboplatin/administration & dosage, Drug Administration Schedule, Endometrial Neoplasms/*drug therapy, Fanning James, Female, Humans, Local/drug therapy, Maseelall Priya, Middle Aged, Neoplasm Recurrence, Paclitaxel/administration & dosage, Phytogenic/administration & dosage, Survival Analysis, Treatment Outcome
Tags: 2015, 80 and over, Adenocarcinoma/drug therapy/mortality/pathology, adenoid cystic carcinoma, Adenoid Cystic/*drug therapy/mortality/pathology, Adult, Aged, Antineoplastic Agents/*therapeutic use, Blumenschein George R Jr, Carcinoma, Department of Internal Medicine, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, El-Naggar Adel K, Female, Gefitinib, Glisson Bonnie S, Gonzalez-Angulo Ana M, Head & neck, Humans, Jakob John A, Kies Merrill S, Kupferman Michael E, Lee J Jack, Liu Diane D, Local/*drug therapy/mortality/pathology, Male, Maximum Tolerated Dose, Middle Aged, NEOMED College of Medicine, Neoplasm Invasiveness/pathology, Neoplasm Recurrence, Neoplasm Staging, non-adenoid cystic carcinoma, Prognosis, Quinazolines/*therapeutic use, Remission Induction, response to therapy, salivary gland cancer, Salivary Gland Neoplasms/*drug therapy/mortality/pathology, Survival Analysis, Treatment Outcome